Global Alzheimer's Disease Drugs Market Growth 2019-2024
Table of Contents
2019-2024 Global Alzheimer's Disease Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Alzheimer's Disease Drugs Consumption 2014-2024
- 2.1.2 Alzheimer's Disease Drugs Consumption CAGR by Region
- 2.2 Alzheimer's Disease Drugs Segment by Type
- 2.2.1 Cholinesterase Inhibitors
- 2.2.2 NMDA Antagonists
- 2.3 Alzheimer's Disease Drugs Consumption by Type
- 2.3.1 Global Alzheimer's Disease Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Alzheimer's Disease Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Alzheimer's Disease Drugs Sale Price by Type (2014-2019)
- 2.4 Alzheimer's Disease Drugs Segment by Application
- 2.4.1 Drug Stores
- 2.4.2 Retail Stores
- 2.4.3 Others
- 2.5 Alzheimer's Disease Drugs Consumption by Application
- 2.5.1 Global Alzheimer's Disease Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Alzheimer's Disease Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Alzheimer's Disease Drugs Sale Price by Application (2014-2019)
3 Global Alzheimer's Disease Drugs by Players
- 3.1 Global Alzheimer's Disease Drugs Sales Market Share by Players
- 3.1.1 Global Alzheimer's Disease Drugs Sales by Players (2017-2019)
- 3.1.2 Global Alzheimer's Disease Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Alzheimer's Disease Drugs Revenue Market Share by Players
- 3.2.1 Global Alzheimer's Disease Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Alzheimer's Disease Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Alzheimer's Disease Drugs Sale Price by Players
- 3.4 Global Alzheimer's Disease Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Alzheimer's Disease Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Alzheimer's Disease Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Alzheimer's Disease Drugs by Regions
- 4.1 Alzheimer's Disease Drugs by Regions
- 4.1.1 Global Alzheimer's Disease Drugs Consumption by Regions
- 4.1.2 Global Alzheimer's Disease Drugs Value by Regions
- 4.2 Americas Alzheimer's Disease Drugs Consumption Growth
- 4.3 APAC Alzheimer's Disease Drugs Consumption Growth
- 4.4 Europe Alzheimer's Disease Drugs Consumption Growth
- 4.5 Middle East & Africa Alzheimer's Disease Drugs Consumption Growth
5 Americas
- 5.1 Americas Alzheimer's Disease Drugs Consumption by Countries
- 5.1.1 Americas Alzheimer's Disease Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Alzheimer's Disease Drugs Value by Countries (2014-2019)
- 5.2 Americas Alzheimer's Disease Drugs Consumption by Type
- 5.3 Americas Alzheimer's Disease Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Alzheimer's Disease Drugs Consumption by Countries
- 6.1.1 APAC Alzheimer's Disease Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Alzheimer's Disease Drugs Value by Countries (2014-2019)
- 6.2 APAC Alzheimer's Disease Drugs Consumption by Type
- 6.3 APAC Alzheimer's Disease Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Alzheimer's Disease Drugs by Countries
- 7.1.1 Europe Alzheimer's Disease Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Alzheimer's Disease Drugs Value by Countries (2014-2019)
- 7.2 Europe Alzheimer's Disease Drugs Consumption by Type
- 7.3 Europe Alzheimer's Disease Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Alzheimer's Disease Drugs by Countries
- 8.1.1 Middle East & Africa Alzheimer's Disease Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Alzheimer's Disease Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Alzheimer's Disease Drugs Consumption by Type
- 8.3 Middle East & Africa Alzheimer's Disease Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Alzheimer's Disease Drugs Distributors
- 10.3 Alzheimer's Disease Drugs Customer
11 Global Alzheimer's Disease Drugs Market Forecast
- 11.1 Global Alzheimer's Disease Drugs Consumption Forecast (2019-2024)
- 11.2 Global Alzheimer's Disease Drugs Forecast by Regions
- 11.2.1 Global Alzheimer's Disease Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Alzheimer's Disease Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Alzheimer's Disease Drugs Forecast by Type
- 11.8 Global Alzheimer's Disease Drugs Forecast by Application
12 Key Players Analysis
- 12.1 Eisai
- 12.1.1 Company Details
- 12.1.2 Alzheimer's Disease Drugs Product Offered
- 12.1.3 Eisai Alzheimer's Disease Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Eisai News
- 12.2 Forest Laboratories
- 12.2.1 Company Details
- 12.2.2 Alzheimer's Disease Drugs Product Offered
- 12.2.3 Forest Laboratories Alzheimer's Disease Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Forest Laboratories News
- 12.3 H. Lundbeck
- 12.3.1 Company Details
- 12.3.2 Alzheimer's Disease Drugs Product Offered
- 12.3.3 H. Lundbeck Alzheimer's Disease Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 H. Lundbeck News
- 12.4 Johnson and Johnson
- 12.4.1 Company Details
- 12.4.2 Alzheimer's Disease Drugs Product Offered
- 12.4.3 Johnson and Johnson Alzheimer's Disease Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Johnson and Johnson News
- 12.5 Merz Pharma
- 12.5.1 Company Details
- 12.5.2 Alzheimer's Disease Drugs Product Offered
- 12.5.3 Merz Pharma Alzheimer's Disease Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Merz Pharma News
- 12.6 Novartis
- 12.6.1 Company Details
- 12.6.2 Alzheimer's Disease Drugs Product Offered
- 12.6.3 Novartis Alzheimer's Disease Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Novartis News
- 12.7 Pfizer
- 12.7.1 Company Details
- 12.7.2 Alzheimer's Disease Drugs Product Offered
- 12.7.3 Pfizer Alzheimer's Disease Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Pfizer News
...
13 Research Findings and Conclusion
Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time.
According to this study, over the next five years the Alzheimer's Disease Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Alzheimer's Disease Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Alzheimer's Disease Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Alzheimer's Disease Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Cholinesterase Inhibitors
NMDA Antagonists
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Drug Stores
Retail Stores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Eisai
Forest Laboratories
H. Lundbeck
Johnson and Johnson
Merz Pharma
Novartis
Pfizer
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Alzheimer's Disease Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Alzheimer's Disease Drugs market by identifying its various subsegments.
Focuses on the key global Alzheimer's Disease Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Alzheimer's Disease Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Alzheimer's Disease Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.